METHYL 4-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)METHYL)BENZOATE, 95%, 1g

Tetramethylammonium hydroxide, 10% aqueous solution, 25.0%, 500ml

1H-1,2,3-Triazole, 98.0%, 5g

3-((1-(Tert-butoxycarbonyl)piperidin-4-yl)methyl)benzoic acid, 95%, 500mg

(5aR,10bS)-2-(2,4,6-Trichlorophenyl)-4,5a,6,10b-tetrahydroindeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium tetrafluoroborate, 97%, 1g

5-Bromo-3-nitropicolinaldehyde, 95.0%, 1g

(R)-(2,3-Dimethoxyphenyl)(1-(4-fluorophenethyl)piperidin-4-yl)methanol, 95.0%, 5mg

5-Chloro-2,2-dimethyl-pentanoic acid isobutylester, 97.0%, 10g

Pentyl isothiocyanate, 99.0%, 1g

6-Bromo-4-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 5g

Ethyl 3-amino-2,5-dichlorobenzoate, 97%, 100mg

(1-(2-Methoxyphenyl)cyclopropyl)methanamine, 95%, 1g

4-Amino-1-methylpyrimidin-2(1H)-one, 95.0%, 250mg